Study 16 of 22IGF-1 DES (Des(1-3) IGF-1) literatureNature metabolismTop journal2026

Neutrophil serine proteases inhibit thermogenic capacity of visceral white adipose tissue.

Not reported in abstract.

Read at Nature metabolism Add to compare

Where it sits

this study against the rest of the igf-1 des (des(1-3) igf-1) corpus

Preclinical · this one

Observational

Open-label

Randomised

Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →

2026

Abstract

The authors’ words, as Nature metabolism supplied them

Neutrophils and neutrophil-derived serine proteases (NSPs), including neutrophil elastase (NE) and proteinase 3 (PR3), are present in visceral fat of individuals and rodents with obesity, yet their roles in energy metabolism remain elusive. Here we show that neutrophil infiltration and NSP activation impair visceral fat browning in response to β-adrenergic receptor stimulation or cold exposure in male mice. Genetic deletion or local pharmacological inhibition of NE with sivelestat rescued visceral fat browning and enhanced thermogenesis. Mechanistically, NE/PR3 directly suppresses beige adipogenesis by arresting cell cycle via CDK4/cyclin D1 downregulation, impairs beige adipocyte differentiation by degrading insulin-like growth factor binding protein-3, and indirectly promotes M1 macrophage polarization. Administration of sivelestat suppressed diet-induced neutrophil infiltration, enhanced cold-induced visceral fat browning and decreased visceral fat content in mice. These findings reveal an unexpected inhibitory role of NSPs in visceral fat browning and suggest the potential of repurposing sivelestat as an anti-obese drug.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the IGF-1 DES (Des(1-3) IGF-1) corpus

CDetection of LongR3 -IGF-I, Des(1-3)-IGF-I, and R3 -IGF-I using immunopurification and high resolution mass spectrometry for antidoping purposes.Drug testing and analysis · Des(1-3)-IGF-I and R3-IGF-I detectable until 24 h after 100 μg/kg IM injection in rats.Animal BN-terminal truncated insulin-like growth factor-I in human urine.The Journal of clinical endocrinology and metabolism · 1995 · Total urinary IGF-I level was 216.0 +/- 41.1 ng/L (mean +/- SEM).Human CInteractions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth.The Journal of clinical endocrinology and metabolism · 1999 · Not reported in abstract.In vitro CThe role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers.The Journal of clinical endocrinology and metabolism · 2004 · Not reported in abstract.In vitro BPost-Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study.DEN open · 2023 · n=102 · 8% of patients experienced bleeding.Human BBethesda Endoscopic Retrograde Cholangiopancreatography Skill Assessment Tool (BESAT)-Based Simulator Training Using a Novel Dry Endoscopic Retrograde Cholangiopancreatography Model Improves Technical Proficiency and Self-Efficacy: A Prospective Study.DEN open · 2026 · n=30 · EST success rate increased from 43.3% to 76.7% (p < 0.05).Human